Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Lloberas N; Departments of aNephrology bPharmacy, IDIBELL, Bellvitge University Hospital cDepartment of Pharmacy and Pharmaceutical Technology, Biopharmaceutics and Pharmacokinetics Unit, School of Pharmacy, University of Barcelona, Barcelona, Spain dDepartment of Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute eLouvain Centre for Toxicology and Applied Pharmacology, Experimental and Clinical Research Institute, Catholic University of Louvain, Brussels, Belgium Departments of fInternal Medicine gHospital Pharmacy hClinical Biochemistry, Erasmus MC, University Medical Center Rotterdam, The Netherlands.; Elens L
Subjects: Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/*genetics ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage ; Kidney Transplantation/Kidney Transplantation/Kidney Transplantation/*adverse effects
-
Source:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2017 Sep; Vol. 27 (9), pp. 313-322.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print Cited Medium: Internet
Record details
-
Authors :
Genvigir FD; aDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences bDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo cNephrology Division, Hospital do Rim, Universidade Federal de São Paulo, Sao Paulo, Brazil dCenter of Molecular Biology and Pharmacogenetics, BIOREN-CEGIN, Universidad de La Frontera, Temuco, Chile eSchool of Medicine, Uniformed Services University, Bethesda, Maryland, USA.; Salgado PC
Subjects: Pharmacogenomic Variants*; Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/*genetics ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacokinetics
-
Source:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2016 Oct; Vol. 26 (10), pp. 462-72.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print Cited Medium: Internet
Record details
-
Authors :
Lamba V; aDepartment of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.; Sangkuhl K
Subjects: Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacokinetics ; Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*pharmacokinetics; Genetic Variation
-
Source:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2014 Jan; Vol. 24 (1), pp. 73-9.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print Cited Medium: Internet
Record details
-
Authors :
Barbarino JM; Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pharmaceutical Sciences, School of Pharmacy dDepartment of Pathology, School of Medicine, Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA eSchool of Pharmacy, University of Queensland, Brisbane, Australia.; Staatz CE
Subjects: Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacokinetics ; Cyclosporine*/Cyclosporine*/Cyclosporine*/pharmacology ; Cyclosporine*/Cyclosporine*/Cyclosporine*/therapeutic use
-
Source:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2013 Oct; Vol. 23 (10), pp. 563-85.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print Cited Medium: Internet
Record details
-
Authors :
Rojas LE; aDepartment of Internal Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile bPharmacogenetic Unit, Drugs Clinical Area, Hospital Universitari i Politècnic La Fe e Instituto de Investigación Sanitaria La Fe. cHepatology Unit. Hospital Universitari i Politècnic La Fe dClinical Pharmacology Unit, Drugs Clinical Area, Hospital Universitari i Politècnic La Fe eDepartment of Pharmacology, Faculty of Medicine, Universitat de Valencia fCenter for Public Health Research-Valencia (CSISP-FISABIO), Health Services Research Network in Chronic Diseases (RESISSEC), Valencia, Spain.; Herrero MJ
Subjects: Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/*genetics ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacokinetics ; Tacrolimus/Tacrolimus/Tacrolimus/*pharmacokinetics
-
Source:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2013 Oct; Vol. 23 (10), pp. 509-17.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print Cited Medium: Internet
Record details
